Data-Driven Bioprocess Development From Molecule To GMP Manufacturing

Transitioning a biologic from discovery to commercial production requires balancing product quality with process scalability. Because complex proteins and diverse cell lines present distinct structural demands, successful development depends on a molecule-centered strategy rather than a rigid, standardized format. Engineers must systematically refine critical environmental parameters—such as feeding strategies, gassing behaviors, and media compositions—to establish robust, repeatable baselines early in the lifecycle.

Achieving predictable scale-up requires addressing hardware compatibility and data continuity before technology transfer begins. Utilizing modular, benchtop bioreactor systems that flexibly accommodate both glass and single-use vessels allows development teams to seamlessly adjust to shifting material volume requirements. Furthermore, integrating advanced online sensing technologies—such as Raman spectroscopy—and predictive machine learning platforms shifts the industry away from historical empirical designs toward model-informed, adaptive control strategies.

Gain valuable technical insights into overcoming tech-transfer deviations, evaluating clone scalability under benchtop conditions, and leveraging data ecosystems for remote process monitoring. Read the full expert interview to optimize your upstream workflows.